drugset / Trial / NCT02425735

Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer

NCT02425735

RandomizedSingle-groupSingle-blindTreatment

Summary

In this study, effects of γδT cells on human hepatocellular liver cancer in combination with tumor reducing surgery, for example cryosurgery going to be investigated.

Timeline

Start
2015-04
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DC-CIK cells Cell therapy
Subject γδ T cells Cell therapy